Clinical nephrology
Dose response of PTH and FGF23 to paricalcitol in patients with end-stage renal failure on chronic intermittent hemodialysis.
Nicolaus Mussmaecher, Steffen Mitzner, Christian Haas, Martin Busch, Markus Ketteler, Christoph Wanner, Patrick Biggar
Published: 202510.5414/CN111768
Abstract
OBJECTIVES: The aim of this study was to determine the differential dose response of parathyroid hormone (PTH) and fibroblast growth factor (FGF23) to paricalcitol in patients with secondary hyperparathyroidism and end-stage renal failure on chronic…
Preview only. Read the full abstract at the source